Vyteris’ proprietary active transdermal drug delivery technology delivers drugs comfortably through the skin using low-level electrical energy. This active patch technology allows precise dosing, giving physicians and patients control in the rate, dosage, and pattern of drug delivery that can result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration.
With Vyteris’ active patch system, many of the shortcomings of conventional drug delivery methods can be avoided or minimized. The Vyteris smart patch system delivers drug directly to the blood stream, avoiding metabolism by the liver, and reducing the stomach and gastrointestinal upsets that can be associated with oral drug administration. The system is convenient to use and provides a relatively pain free application, avoiding the major drawback of injections and intravenous delivery, and delivers drug doses automatically, minimizing concerns about patient compliance.
And Vyteris’ transdermal drug delivery technology can be utilized for the delivery of many drugs, including many peptides that have, until now, necessitated injections or intravenous infusions. Dr. Russell Potts, PhD, a leading consultant to the medical device industry, explains the role of peptides in the future of healthcare and why the Vyteris smart patch is especially suitable for their delivery, in a short video .
Please click on the links below to learn more about our
active patch technology:
To see how Vyteris’ proprietary technology works,
please watch our MOA Video.
Read about Our Products, including our first product LidoSite® and others in our pipeline.